TGFB1 and atrial fibrillation: In this study, we investigated the relationship between spironolactone and atrial fibrosis by using different doses of spironolactone in the intervention treatment of spontaneously hypertensive rats (SHRs) and explore the dose-dependent effects of spironolactone on TGF-β1 expression and the vulnerability to AF.